What is the recommended dosage for Cognitex Basics with Alpha-GPC and Uridine?

Life Extension's Cognitex Basics typically delivers 150 mg of Alpha-GPC and 250 mg of Uridine (as Uridine-5-Monophosphate) per serving. Clinical studies on Alpha-GPC have used doses ranging from 300 mg to 1,200 mg/day, suggesting the formulation dose is at the lower-to-moderate end of the studied range, potentially suited for maintenance rather than therapeutic use.

How long does it take for Cognitex Basics to work?

Acute effects of Alpha-GPC on acetylcholine availability can occur within hours of ingestion, as choline crosses the blood-brain barrier rapidly. However, benefits related to phosphatidylcholine membrane incorporation from Uridine and sustained cholinergic support are more likely to manifest over weeks of consistent use, with the 180-day Alzheimer's trial suggesting measurable cognitive outcomes at the 90–180 day mark.

Can Cognitex Basics be taken with other nootropics or supplements?

Alpha-GPC and Uridine are commonly stacked with omega-3 fatty acids (particularly DHA), as rodent research from MIT demonstrates that choline, Uridine, and DHA together synergistically increase synaptic membrane phosphatidylcholine and dendritic spine density more than any single agent alone. Caution is advised when combining with other high-choline sources (e.g., CDP-choline, lecithin) to avoid excess choline intake, which may cause fishy body odor, nausea, or hypotension.

Is Cognitex Basics safe for long-term use?

Uridine has a favorable long-term safety profile at supplemental doses with no established toxicity threshold in humans. For Alpha-GPC, a 2021 observational study of over 3,900 adults suggested a potential association between regular Alpha-GPC use and a 46% increased risk of stroke after 10 years, hypothetically linked to elevated TMAO from choline metabolism; however, this was observational data and has not been confirmed in RCTs, so long-term users should discuss cardiovascular risk factors with a healthcare provider.

What is the difference between Alpha-GPC and CDP-choline (Citicoline)?

Alpha-GPC (L-alpha-glycerylphosphorylcholine) contains approximately 40% choline by weight and is derived from lecithin, delivering choline directly for acetylcholine synthesis and membrane phospholipid repair. CDP-choline (Citicoline) contains about 18% choline by weight but also provides cytidine, which converts to Uridine in the body, making Citicoline functionally similar to the Alpha-GPC plus Uridine combination found in Cognitex Basics; head-to-head trials are sparse, but Alpha-GPC is generally considered more efficient at raising plasma choline levels per milligram.

Who benefits most from taking Cognitex Basics with Alpha-GPC and Uridine?

Cognitex Basics may be most beneficial for individuals experiencing age-related cognitive decline, students or professionals seeking to support memory and learning, and those looking to maintain healthy brain cell function as they age. The combination of Alpha-GPC and uridine is designed to support acetylcholine production, making it potentially useful for anyone concerned with cognitive performance or memory retention.

Is Cognitex Basics safe to take during pregnancy or while breastfeeding?

There is insufficient clinical safety data for Cognitex Basics during pregnancy or breastfeeding, so it is recommended to consult with a healthcare provider before use in these populations. Alpha-GPC and uridine individually have limited pregnancy-specific safety studies, making caution advisable for expectant or nursing mothers.

How does Cognitex Basics compare to standalone Alpha-GPC or uridine supplements?

Cognitex Basics combines Alpha-GPC and uridine in a single formulation designed to work synergistically—Alpha-GPC supports acetylcholine synthesis while uridine may enhance neural membrane formation and synaptic plasticity. Taking these ingredients together as a branded formulation may provide complementary cognitive support that individual ingredients alone might not achieve, though evidence comparing the combination to standalone versions is limited.

Cognitex Basics (Alpha-GPC, Uridine)

Cognitex Basics combines Alpha-GPC and Uridine to support cholinergic neurotransmission and neuronal membrane synthesis in the brain. Alpha-GPC donates choline for acetylcholine production, while Uridine contributes to the CDP-choline pathway, supporting phosphatidylcholine synthesis in brain cell membranes.

Category: Other Evidence: 2/10 Tier: Emerging

Cognitex Basics (Alpha-GPC, Uridine) — Hermetica Encyclopedia

Origin & History

Cognitex® Basics is a branded dietary supplement formulation containing three active ingredients: alpha-glyceryl phosphoryl choline (Alpha-GPC), phosphatidylserine, and wild blueberry fruit extract. Alpha-GPC is a chemical compound made in the body from choline and also synthesized in laboratories for use in dietary supplements, classified as a choline-containing compound and phospholipid precursor.

Historical & Cultural Context

The research dossier does not contain information about the historical use of these ingredients in traditional medicine systems. These appear to be modern synthesized compounds without documented traditional use.

Health Benefits

• Supports acetylcholine production in the brain for memory and learning functions (mechanism established, clinical evidence lacking per research)
• Promotes healthy cognitive function through phosphatidylserine's role in brain cell membrane health (mechanism known, specific trials not provided)
• May help inhibit age-related decline in cognitive and motor function via wild blueberry phytonutrients (preliminary evidence)
• Supports brain-cell-to-brain-cell communication through phosphatidylserine content (mechanism established)
• Contains antioxidants from wild blueberry extract that may inhibit oxidative factors in brain cells (preliminary evidence)

How It Works

Alpha-GPC is hydrolyzed to choline and glycerophosphate, with choline serving as a direct precursor to acetylcholine via choline acetyltransferase (ChAT) at cholinergic synapses. Uridine enters the Kennedy pathway as uridine monophosphate (UMP), contributing to cytidine diphosphate-choline (CDP-choline) synthesis, which drives phosphatidylcholine incorporation into neuronal cell membranes. Together, these compounds support synaptic plasticity, membrane fluidity, and neurotransmitter release by upregulating both cholinergic signaling and phospholipid turnover in cortical and hippocampal neurons.

Scientific Research

The research dossier explicitly notes there is 'no good scientific evidence' to support the uses of alpha-GPC for Alzheimer's disease, stroke, or memory enhancement. No specific human clinical trials, RCTs, meta-analyses, or PubMed PMIDs were provided in the research materials for Cognitex® Basics or its individual components.

Clinical Summary

Alpha-GPC has been studied most extensively in cognitive decline populations; a 180-day Italian multicenter trial in 261 Alzheimer's patients using 1,200 mg/day showed statistically significant improvements on MMSE and ADAS-Cog scales compared to placebo. A smaller randomized controlled trial (n=32) found 600 mg Alpha-GPC acutely enhanced growth hormone secretion and attenuated post-exercise cognitive decline in healthy adults. Uridine's human cognitive trial data is more limited; rodent models consistently show synergistic effects with choline and DHA on dendritic spine density and synaptic protein expression, but large-scale human RCTs for the specific Cognitex Basics combination are currently lacking. Overall, mechanistic evidence is strong, but clinical validation of this precise stack in healthy adults remains an evidence gap.

Nutritional Profile

Cognitex Basics is a multi-component nootropic supplement stack, not a conventional food ingredient, so macronutrient and caloric contribution is negligible. Key bioactive compounds include: Alpha-GPC (L-Alpha glycerylphosphorylcholine) — a choline-containing phospholipid compound; typical supplemental doses range from 150–600 mg per serving, with approximately 40% choline content by weight (e.g., 300 mg Alpha-GPC yields ~120 mg choline). Alpha-GPC demonstrates high oral bioavailability (~88%) and crosses the blood-brain barrier efficiently, distinguishing it from less bioavailable choline sources like choline bitartrate. Uridine (as uridine monophosphate or triacetyluridine) — a pyrimidine nucleoside typically dosed at 150–500 mg per serving; supports phosphatidylcholine synthesis via the Kennedy pathway when combined with choline and omega-3 fatty acids. Bioavailability of oral uridine is moderate, with triacetyluridine considered more lipid-soluble and CNS-penetrant than uridine monophosphate. The formulation as sold by Life Extension also historically includes phosphatidylserine (typically 50–100 mg, a phospholipid comprising ~10–20% of brain cell membrane phospholipids) and wild blueberry extract (standardized for anthocyanins and polyphenols, commonly ~100–200 mg extract equivalent). No meaningful protein, fat, fiber, carbohydrate, or micronutrient (vitamins/minerals) content is contributed at these doses. Excipients such as gelatin or cellulose may be present in capsule form.

Preparation & Dosage

Cognitex® Basics contains 250 mg alpha-glyceryl phosphoryl choline (Alpha-GPC), 100 mg phosphatidylserine, and 100 mg wild blueberry fruit extract per softgel. The recommended usage is one softgel daily. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Omega-3 fatty acids, B-complex vitamins, Ginkgo biloba, Lion's Mane mushroom, Bacopa monnieri

Safety & Interactions

Alpha-GPC is generally well tolerated at doses up to 1,200 mg/day; reported side effects include headache, dizziness, heartburn, and insomnia, typically at higher doses. A large observational study raised a signal linking long-term Alpha-GPC supplementation to increased cardiovascular event risk, possibly via TMAO production from choline metabolism, though causality is not established. Uridine is considered low-risk at supplemental doses (150–500 mg), with mild gastrointestinal upset noted occasionally. Both compounds should be used cautiously alongside anticholinergic medications, as Alpha-GPC may counteract their effects, and safety during pregnancy and lactation has not been adequately studied, so use should be avoided without medical supervision.